Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05866705 · ClinicalTrials.gov registry record
The Mental Health Experiences of Sexual and Gender Minorities Living With Cancer and Their Care Partners
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 41
- Enrollment target
NCT05866705: Completed study, sponsored by University of Alabama at Birmingham.
NCT05866705 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05866705 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to examine relationships between contextual stressors and stress moderators, depression symptom experience, resilience, frailty, and quality of life among older sexual gender minorities cancer survivors and their care partners.
Primary Outcome
PROMIS Emotional Distress-Depression Short Form, a 4-item scale measuring common symptoms associated with depresison.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-04-03 |
| Est. Completion | 2024-08-27 |
What the finished NCT05866705 record still lists
NCT05866705 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 41 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT05866705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05866705 about?
NCT05866705 is a clinical study titled "The Mental Health Experiences of Sexual and Gender Minorities Living With Cancer and Their Care Partners". The purpose of this study is to examine relationships between contextual stressors and stress moderators, depression symptom experience, resilience, frailty, and quality of life among older sexual gender minorities cancer survivors and their care partners.
What is the current status of trial NCT05866705?
This trial is currently completed. The enrollment target is 41 participants. The study started on 2023-04-03. Estimated completion is 2024-08-27.
Who is sponsoring clinical trial NCT05866705?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI